Literature DB >> 10681508

TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss Of response in tumor cells.

W A Campbell1, D E Sah, M M Medina, J E Albina, W B Coleman, N L Thompson.   

Abstract

Tumor associated gene-1/L amino acid transporter-1 (TA1/LAT-1) was recently identified as a light chain of the CD98 amino acid transporter and cellular activation marker. Our previous studies with primary rat hepatocyte cultures demonstrated that TA1 RNA levels were responsive to media amino acid concentrations, suggesting adaptive regulation. High level TA1 expression associated with transformed cells also suggested a role in tumor progression. The present study examined the relationship of TA1/CD98 expression, adaptive response, and associated amino acid transport to neoplastic transformation using a panel of well characterized rat hepatic cell lines. We found 1) increased expression of TA1 in response to amino acid depletion, specific for arginine but not glutamine; 2) loss of TA1 response to arginine in gamma-glutamyl transpeptidase-positive transformed and tumorigenic cells; 3) no appreciable response of 4F2/CD98 heavy chain to arginine levels; and 4) correlation of system L amino acid transport activity in response to arginine with changes in TA1/LAT-1 mRNA but not total immunoreacting protein. Our results suggest this CD98 light chain may act as an environmental sensor, responding to amino acid availability and that its regulation is complex. We hypothesize that altered TA1 expression is an early event in hepatocarcinogenesis giving neoplastic cells a growth or survival advantage, particularly under conditions of limited amino acid availability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681508     DOI: 10.1074/jbc.275.8.5347

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Expression of heteromeric amino acid transporters along the murine intestine.

Authors:  Mital H Dave; Nicole Schulz; Marija Zecevic; Carsten A Wagner; Francois Verrey
Journal:  J Physiol       Date:  2004-05-21       Impact factor: 5.182

3.  An amino acid transporter involved in gastric acid secretion.

Authors:  Philipp Kirchhoff; Mital H Dave; Christine Remy; Ortrud Kosiek; Stephanie M Busque; Matthias Dufner; John P Geibel; Francois Verrey; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2005-11-25       Impact factor: 3.657

4.  Role of the L-amino acid transporter-1 (LAT-1) in mouse trophoblast cell invasion.

Authors:  M K Chrostowski; B G McGonnigal; J P Stabila; J F Padbury
Journal:  Placenta       Date:  2010-04-24       Impact factor: 3.481

Review 5.  CD98 at the crossroads of adaptive immunity and cancer.

Authors:  Joseph M Cantor; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2012-04-12       Impact factor: 5.285

Review 6.  The role of CD98 in astrocytic neoplasms.

Authors:  Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Namiko Nomura; Akiko Yano; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

7.  Genomic regulation of intestinal amino acid transporters by aldosterone.

Authors:  João S Amaral; Maria João Pinho; Patrício Soares-da-Silva
Journal:  Mol Cell Biochem       Date:  2008-03-18       Impact factor: 3.396

8.  Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.

Authors:  Toshio Sasajima; Tadashi Miyagawa; Takamitsu Oku; Juri G Gelovani; Ronald Finn; Ronald Blasberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-13       Impact factor: 9.236

9.  The alpha4-containing form of protein phosphatase 2A in liver and hepatic cells.

Authors:  Sunny J-S Yoo; Rosa H Jimenez; Jennifer A Sanders; Joan M Boylan; David L Brautigan; Philip A Gruppuso
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

10.  Rapamycin response in tumorigenic and non-tumorigenic hepatic cell lines.

Authors:  Rosa H Jimenez; Joan M Boylan; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Jennifer A Sanders; Philip A Gruppuso
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.